We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease (DREPHAPLO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03240731
Recruitment Status : Active, not recruiting
First Posted : August 7, 2017
Last Update Posted : August 18, 2022
Association Clinique Thérapeutique Infantile du val de Marne
Information provided by (Responsible Party):
Nathalie Dhédin, Saint-Louis Hospital, Paris, France

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2024
Estimated Study Completion Date : September 2025